Image source: The Motley Fool.
GlycoMimetics (NASDAQ: GLYC)
Q2 2022 Earnings Call
Aug 03, 2022 , 8:30 a.m. ET
Operator
For further details see:
GlycoMimetics (GLYC) Q2 2022 Earnings Call TranscriptImage source: The Motley Fool.
GlycoMimetics (NASDAQ: GLYC)
Q2 2022 Earnings Call
Aug 03, 2022 , 8:30 a.m. ET
Operator
For further details see:
GlycoMimetics (GLYC) Q2 2022 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Topline results from pivotal Phase 3 study of uproleselan in relapsed/refractory (R/R) Acute Myeloid Leukemia (AML) to be reported in Q2 2024 New Drug Application (NDA) for uproleselan to be submitted to the U.S. Food and Drug Administration (FDA) by end of 2024 if outcome of R/R AML pivotal ...